A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

by | Aug 6, 2025 | Clinical Trials | 0 comments

​ Conditions: ALS (Amyotrophic Lateral Sclerosis)

Interventions: Drug: LY4256984; Drug: Placebo

Sponsors: Eli Lilly and Company

Not yet recruiting Conditions: ALS (Amyotrophic Lateral Sclerosis)
Interventions: Drug: LY4256984; Drug: Placebo
Sponsors: Eli Lilly and Company
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *